| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.45B | -5.2% | +68.1% |
| Cost of Revenue | $4.41B | -4.6% | +68.6% |
| Gross Profit | $1.04B | -7.6% | +66.0% |
| R&D Expense | $38.0M | -17.4% | +40.7% |
| SG&A Expense | $440.0M | +1.1% | +49.2% |
| Operating Income | $331.0M | -28.2% | +11.4% |
| Pre-tax Income | $178.0M | -42.4% | -20.5% |
| Income Tax | $3.0M | -93.9% | -94.8% |
| Net Income | $177.0M | -32.4% | +8.6% |
| EPS (Basic) | $0.38 | +236.3% | +236.3% |
| EPS (Diluted) | $0.38 | +236.3% | +236.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.06B | +28.1% | +137.5% |
| Accounts Receivable | $3.16B | -7.8% | +78.1% |
| Current Assets | $8.56B | +0.3% | +74.5% |
| Total Assets | $37.05B | -0.3% | +129.2% |
| Current Liabilities | $6.58B | -19.6% | +68.8% |
| Long-term Debt | $14.62B |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $370.0M | +378.2% | — |
| Investing Cash Flow | -$441.0M | -95.1% | — |
| Financing Cash Flow | $291.0M | -18.7% | — |
| +113.8% |
| Total Liabilities | $25.40B | -0.1% | +105.3% |
| Stockholders' Equity | $11.64B | -0.7% | +207.5% |